About Us
SIAMAF Healthcare is a cancer theranostics company developing magnetic nanotechnology for radiation free and affordable cancer diagnosis and therapy. Bringing innovative solutions for cancer staging, screening, localization, imaging, and hyperthermia. We are a team of scientists, engineers, and clinicians with significant global research and industry experience in nanotechnology and biotechnology. We are committed to solve some of the challenging healthcare problems through innovative, practical, and cutting-edge technology solutions.
Products
MafPro
MafCyto
MafCyto
MafPro is an ultrasensitive hand-held magnetic probe system for staging and localisations of breast, head & neck, and colorectal cancer. The device can tell the exact location of the tumor and how far cancer has spread by using nanomagnetic sensing technology. The device offers quality and value of care benefits to cancer patients, doctors, and hospital administrators by adding greater flexibility, precision and removing the need for both wires and nuclear medicine.
MafCyto
MafCyto
MafCyto
MafCyto is a novel magnetic blood filtration system to help treat cytokine release syndrome (CRS), a potentially life-threatening condition in cancer, sepsis, and COVID-19 patients. The device can remove cytokines, toxins, pathogens, cells, and other targets directly from a patient’s bloodstream using magnetic nanoparticle-based filtration system. Any component in the bloodstream can be specifically targeted by magnetic nanoparticles and removed by applying selective magnetic field.
MafTherm
MafScreen
MafScreen
MafTherm is a magnetic hyperthermia system provides a radiation free alternative to treat cancer more effectively and with fewer side effects. FDA approved magnetic nanoparticles are introduced directly into the tumor and subsequently heated by applying an alternating magnetic field externally to destroy cancer cells.
MafScreen
MafScreen
MafScreen
MafScreen is a cancer screening system to help detect cancer early. The device can diagnose several types of cancer from a single drop of blood. The device uses microfluidics, magnetic nanotechnology, high speed camera technology, and AI for specific isolation and identification of cancer cells.
Supported By
